Healthcare Sector Stocks
The Healthcare sector has a total of 1068 stocks, with a combined market cap of $8.18 trillion, total revenue of $4.53 trillion and a weighted average PE ratio of 40.71.
Market Cap
8.18T
Revenue
4.53T
Profits
201B
PE Ratio
40.71
Profit Margin
4.44%
Dividend Yield
0.43%
1069 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 790.98B | -3.67% | 4,463,201 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 547.64B | -1.37% | 6,067,304 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 351.47B | -1.11% | 7,605,494 | 61.16B |
| 4 | UNH | UnitedHealth Group Incorporated | 322.34B | 0.10% | 8,554,584 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 292.25B | -1.33% | 2,388,268 | 58.74B |
| 6 | MRK | Merck & Co., Inc. | 276.38B | -2.37% | 7,059,859 | 65.01B |
| 7 | NVS | Novartis AG | 276.01B | -1.36% | 1,299,732 | 56.67B |
| 8 | AMGN | Amgen Inc. | 185.95B | -1.17% | 2,201,093 | 36.75B |
| 9 | NVO | Novo Nordisk A/S | 180.69B | 6.88% | 25,017,416 | 48.59B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 174.55B | 0.64% | 2,684,516 | 45.20B |
| 11 | ISRG | Intuitive Surgical, Inc. | 170.78B | 0.71% | 2,655,000 | 10.58B |
| 12 | GILD | Gilead Sciences, Inc. | 161.86B | -2.42% | 5,965,675 | 29.44B |
| 13 | ABT | Abbott Laboratories | 158.72B | -1.46% | 12,800,388 | 45.13B |
| 14 | PFE | Pfizer Inc. | 153.59B | 1.24% | 42,500,212 | 62.58B |
| 15 | DHR | Danaher Corporation | 125.45B | -0.74% | 6,410,763 | 24.78B |
| 16 | SYK | Stryker Corporation | 125.43B | -0.65% | 1,675,334 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 119.87B | -0.53% | 6,822,838 | 48.19B |
| 18 | SNY | Sanofi | 113.21B | -1.58% | 2,922,464 | 54.85B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 109.45B | -1.11% | 1,127,921 | 12.00B |
| 20 | GSK | GSK plc | 108.91B | -2.14% | 5,048,833 | 43.97B |
| 21 | MDT | Medtronic plc | 106.97B | -0.56% | 6,570,141 | 35.48B |
| 22 | MCK | McKesson Corporation | 101.43B | -0.96% | 692,330 | 397.96B |
| 23 | CVS | CVS Health Corporation | 99.89B | -1.17% | 7,374,064 | 399.83B |
| 24 | HCA | HCA Healthcare, Inc. | 96.68B | -8.77% | 3,319,996 | 76.39B |
| 25 | BSX | Boston Scientific Corporation | 92.25B | -5.51% | 17,691,303 | 20.61B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.13B | -1.89% | 809,391 | 14.34B |
| 27 | ELV | Elevance Health, Inc. | 74.87B | -0.44% | 1,630,587 | 200.42B |
| 28 | CI | The Cigna Group | 72.68B | -1.46% | 1,594,734 | 274.90B |
| 29 | COR | Cencora, Inc. | 59.95B | -1.03% | 1,609,956 | 325.78B |
| 30 | MDLN | Medline Inc. | 58.80B | -3.18% | 7,317,878 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 52.84B | -0.12% | 1,472,146 | 28.48B |
| 32 | ZTS | Zoetis Inc. | 49.15B | 0.70% | 4,185,102 | 9.47B |
| 33 | EW | Edwards Lifesciences Corporation | 48.52B | 5.56% | 11,816,696 | 6.30B |
| 34 | ARGX | argenx SE | 48.50B | -0.98% | 339,092 | 4.24B |
| 35 | CAH | Cardinal Health, Inc. | 47.03B | -2.38% | 1,402,279 | 244.67B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.95B | 0.89% | 598,170 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 43.32B | -1.75% | 2,008,784 | 21.92B |
| 38 | HLN | Haleon plc | 42.68B | 0.52% | 5,697,437 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.52B | -2.63% | 825,556 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.77B | -0.08% | 752,270 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 35.68B | -1.83% | 4,826,803 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 33.36B | 0.33% | 160,887 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 32.65B | 0.99% | 1,496,086 | 7.07B |
| 44 | RMD | ResMed Inc. | 31.89B | 0.15% | 797,416 | 5.40B |
| 45 | GEHC | GE HealthCare Technologies Inc. | 31.41B | -1.52% | 3,587,007 | 20.63B |
| 46 | WAT | Waters Corporation | 30.42B | -0.43% | 869,649 | 3.17B |
| 47 | RPRX | Royalty Pharma plc | 29.27B | -0.52% | 1,981,554 | 2.38B |
| 48 | INSM | Insmed Incorporated | 29.18B | -6.02% | 2,500,870 | 606.42M |
| 49 | NTRA | Natera, Inc. | 28.88B | 1.30% | 986,655 | 2.31B |
| 50 | RVMD | Revolution Medicines, Inc. | 28.46B | 0.61% | 3,501,174 | - |
| 51 | IQV | IQVIA Holdings Inc. | 27.24B | 1.00% | 1,087,271 | 16.31B |
| 52 | BIIB | Biogen Inc. | 27.06B | -1.86% | 723,188 | 9.89B |
| 53 | BNTX | BioNTech SE | 26.67B | -0.09% | 543,764 | 3.37B |
| 54 | VEEV | Veeva Systems Inc. | 26.32B | 3.19% | 1,625,199 | 3.20B |
| 55 | MTD | Mettler-Toledo International Inc. | 25.97B | 1.43% | 148,533 | 4.03B |
| 56 | PHG | Koninklijke Philips N.V. | 25.94B | -0.58% | 802,854 | 20.94B |
| 57 | HUM | Humana Inc. | 25.84B | 0.13% | 1,011,793 | 129.66B |
| 58 | UTHR | United Therapeutics Corporation | 24.86B | -0.99% | 301,755 | 3.18B |
| 59 | DXCM | DexCom, Inc. | 23.76B | -1.80% | 3,599,555 | 4.66B |
| 60 | STE | STERIS plc | 21.75B | -0.77% | 446,885 | 5.83B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.73B | -1.63% | 1,038,852 | 11.28B |
| 62 | LH | Labcorp Holdings Inc. | 21.68B | -0.42% | 494,447 | 13.95B |
| 63 | WST | West Pharmaceutical Services, Inc. | 21.63B | -1.14% | 1,286,041 | 3.22B |
| 64 | CNC | Centene Corporation | 20.57B | 1.78% | 6,473,197 | 176.15B |
| 65 | MRNA | Moderna, Inc. | 20.12B | -4.01% | 4,552,280 | 1.94B |
| 66 | ROIV | Roivant Sciences Ltd. | 19.62B | -2.59% | 5,616,021 | 13.31M |
| 67 | ILMN | Illumina, Inc. | 19.43B | 1.95% | 886,423 | 4.34B |
| 68 | INCY | Incyte Corporation | 18.84B | -0.86% | 1,116,994 | 5.14B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 17.67B | -1.28% | 2,762,310 | 8.23B |
| 70 | SMMT | Summit Therapeutics Inc. | 17.14B | -0.85% | 5,253,890 | - |
| 71 | VTRS | Viatris Inc. | 16.99B | -1.08% | 14,564,855 | 14.30B |
| 72 | GMAB | Genmab A/S | 16.46B | -0.41% | 1,091,461 | 3.72B |
| 73 | THC | Tenet Healthcare Corporation | 15.84B | -3.99% | 2,653,760 | 21.31B |
| 74 | BBIO | BridgeBio Pharma, Inc. | 14.21B | 2.25% | 4,134,483 | 502.08M |
| 75 | ASND | Ascendis Pharma A/S | 14.16B | 1.90% | 622,753 | 845.52M |
| 76 | RGC | Regencell Bioscience Holdings Limited | 13.59B | -2.90% | 62,178 | - |
| 77 | ALGN | Align Technology, Inc. | 13.58B | -0.56% | 738,478 | 4.03B |
| 78 | SNN | Smith & Nephew plc | 13.35B | -1.10% | 1,293,382 | 6.16B |
| 79 | PODD | Insulet Corporation | 13.13B | -1.38% | 1,117,015 | 2.71B |
| 80 | PEN | Penumbra, Inc. | 12.97B | -0.93% | 352,314 | 1.40B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 12.84B | -1.93% | 1,203,001 | 2.86B |
| 82 | GMED | Globus Medical, Inc. | 12.83B | 0.52% | 678,552 | 2.94B |
| 83 | COO | The Cooper Companies, Inc. | 12.57B | -0.82% | 2,299,965 | 4.15B |
| 84 | FMS | Fresenius Medical Care AG | 12.27B | 0.13% | 341,542 | 23.05B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.10B | -1.11% | 1,817,359 | 943.71M |
| 86 | JAZZ | Jazz Pharmaceuticals plc | 12.10B | -1.72% | 733,680 | 4.27B |
| 87 | SOLV | Solventum Corporation | 11.88B | -0.64% | 598,232 | 8.33B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.75B | -1.22% | 205,550 | 958.40M |
| 89 | MEDP | Medpace Holdings, Inc. | 11.72B | 4.35% | 907,508 | 2.68B |
| 90 | GH | Guardant Health, Inc. | 11.66B | 1.18% | 1,235,869 | 982.02M |
| 91 | RDY | Dr. Reddy's Laboratories Limited | 11.63B | 0.66% | 2,626,157 | 3.85B |
| 92 | EXEL | Exelixis, Inc. | 11.42B | -2.41% | 2,342,860 | 2.32B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.36B | 1.61% | 3,884,262 | 4.72B |
| 94 | ENSG | The Ensign Group, Inc. | 11.05B | -0.10% | 398,237 | 5.06B |
| 95 | UHS | Universal Health Services, Inc. | 10.64B | -3.77% | 753,552 | 17.36B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.35B | -0.66% | 1,638,706 | 1.09B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.23B | -1.48% | 1,123,213 | 3.22B |
| 98 | EHC | Encompass Health Corporation | 10.14B | 0.12% | 1,025,389 | 5.94B |
| 99 | DVA | DaVita Inc. | 10.01B | -2.05% | 680,977 | 13.64B |
| 100 | BTSG | BrightSpring Health Services, Inc. | 9.87B | 2.03% | 2,239,324 | 12.91B |
| 101 | RVTY | Revvity, Inc. | 9.70B | -0.44% | 1,248,087 | 2.86B |
| 102 | PRAX | Praxis Precision Medicines, Inc. | 9.60B | 4.62% | 345,883 | 7.46M |
| 103 | AXSM | Axsome Therapeutics, Inc. | 9.51B | 1.77% | 527,047 | 638.50M |
| 104 | BAX | Baxter International Inc. | 9.38B | -1.36% | 5,048,604 | 11.24B |
| 105 | TEM | Tempus AI, Inc. | 9.34B | 1.32% | 3,826,437 | 1.27B |
| 106 | MASI | Masimo Corporation | 9.33B | -0.04% | 576,615 | 1.53B |
| 107 | MOH | Molina Healthcare, Inc. | 9.16B | 0.71% | 1,774,029 | 43.10B |
| 108 | ABVX | ABIVAX Société Anonyme | 8.90B | 1.38% | 889,607 | 5.37M |
| 109 | HSIC | Henry Schein, Inc. | 8.90B | -0.87% | 843,651 | 13.18B |
| 110 | PCVX | Vaxcyte, Inc. | 8.56B | -2.11% | 899,885 | - |
| 111 | TECH | Bio-Techne Corporation | 8.48B | 3.80% | 1,983,763 | 1.22B |
| 112 | CRL | Charles River Laboratories International, Inc. | 8.38B | 1.23% | 716,339 | 4.02B |
| 113 | NUVL | Nuvalent, Inc. | 8.22B | -3.26% | 993,434 | - |
| 114 | CYTK | Cytokinetics, Incorporated | 8.12B | -0.24% | 967,119 | 88.04M |
| 115 | KRYS | Krystal Biotech, Inc. | 8.02B | 1.67% | 264,108 | 389.13M |
| 116 | QGEN | Qiagen N.V. | 7.94B | 1.16% | 1,153,398 | 2.09B |
| 117 | ATR | AptarGroup, Inc. | 7.91B | -0.69% | 440,909 | 3.78B |
| 118 | ICLR | ICON Public Limited Company | 7.80B | -3.92% | 1,801,901 | 8.10B |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 7.77B | 2.28% | 218,791 | 2.58B |
| 120 | HALO | Halozyme Therapeutics, Inc. | 7.74B | -1.85% | 1,399,577 | 1.40B |
| 121 | IBRX | ImmunityBio, Inc. | 7.68B | -9.16% | 16,939,761 | 113.29M |
| 122 | GKOS | Glaukos Corporation | 7.11B | 0.50% | 455,022 | 507.44M |
| 123 | HIMS | Hims & Hers Health, Inc. | 6.97B | 8.56% | 43,478,924 | 2.35B |
| 124 | HQY | HealthEquity, Inc. | 6.97B | 6.05% | 796,328 | 1.31B |
| 125 | KYMR | Kymera Therapeutics, Inc. | 6.93B | -2.59% | 393,667 | 39.21M |
| 126 | ACLX | Arcellx, Inc. | 6.75B | -0.02% | 2,215,345 | 22.29M |
| 127 | ERAS | Erasca, Inc. | 6.68B | -4.36% | 5,750,690 | - |
| 128 | RGEN | Repligen Corporation | 6.63B | 3.10% | 1,236,208 | 738.26M |
| 129 | GRFS | Grifols, S.A. | 6.53B | 1.13% | 343,905 | 8.83B |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.38B | -2.55% | 778,706 | 46.02M |
| 131 | BLTE | Belite Bio, Inc | 6.34B | -1.94% | 90,608 | - |
| 132 | APGE | Apogee Therapeutics, Inc. | 6.32B | -3.04% | 537,660 | - |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.11% | 3,220,920 | - |
| 134 | CNTA | Centessa Pharmaceuticals plc | 6.10B | 0.09% | 2,019,828 | 15.00M |
| 135 | TFX | Teleflex Incorporated | 6.04B | -0.07% | 1,041,344 | 1.99B |
| 136 | SYRE | Spyre Therapeutics, Inc. | 6.01B | 0.62% | 600,990 | - |
| 137 | COGT | Cogent Biosciences, Inc. | 5.93B | 1.85% | 1,139,398 | - |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.85B | 0.58% | 310,208 | 189.76M |
| 139 | CELC | Celcuity Inc. | 5.85B | 6.58% | 1,070,889 | - |
| 140 | IMVT | Immunovant, Inc. | 5.82B | -1.14% | 1,359,492 | - |
| 141 | CGON | CG Oncology, Inc. | 5.80B | -1.73% | 507,020 | 4.04M |
| 142 | CAI | Caris Life Sciences, Inc. | 5.71B | 2.07% | 830,351 | 812.03M |
| 143 | PTCT | PTC Therapeutics, Inc. | 5.66B | -0.52% | 640,428 | 1.73B |
| 144 | CHE | Chemed Corporation | 5.65B | 9.96% | 606,971 | 2.54B |
| 145 | BLCO | Bausch + Lomb Corporation | 5.64B | 0.25% | 256,264 | 5.10B |
| 146 | PACS | PACS Group, Inc. | 5.57B | 1.08% | 714,405 | 5.29B |
| 147 | BRKR | Bruker Corporation | 5.56B | 0.91% | 1,395,260 | 3.44B |
| 148 | ALKS | Alkermes plc | 5.54B | -1.77% | 912,291 | 1.48B |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 5.52B | -0.50% | 442,381 | 521.31M |
| 150 | LNTH | Lantheus Holdings, Inc. | 5.48B | 1.82% | 476,463 | 1.54B |
| 151 | TGTX | TG Therapeutics, Inc. | 5.41B | -0.81% | 1,365,141 | 616.29M |
| 152 | AVTR | Avantor, Inc. | 5.34B | 1.80% | 8,504,603 | 6.55B |
| 153 | SRRK | Scholar Rock Holding Corporation | 5.34B | -2.11% | 1,294,644 | - |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.27B | -0.31% | 601,370 | 7.50M |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 2,079,640 | 1.00B |
| 156 | OSCR | Oscar Health, Inc. | 5.00B | 2.31% | 3,256,299 | 11.70B |
| 157 | CORT | Corcept Therapeutics Incorporated | 4.94B | 2.17% | 632,562 | 761.41M |
| 158 | WAY | Waystar Holding Corp. | 4.88B | 2.29% | 1,886,152 | 1.10B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | -2.71% | 349,226 | 2.04M |
| 160 | CRSP | CRISPR Therapeutics AG | 4.70B | -11.59% | 3,851,211 | 3.51M |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 4.61B | 1.22% | 171,346 | 268.09M |
| 162 | FOLD | Amicus Therapeutics, Inc. | 4.55B | 0.21% | 5,285,334 | 634.21M |
| 163 | RDNT | RadNet, Inc. | 4.51B | 2.11% | 381,250 | 2.04B |
| 164 | OPCH | Option Care Health, Inc. | 4.46B | -0.49% | 1,531,579 | 5.65B |
| 165 | SHC | Sotera Health Company | 4.44B | 1.63% | 2,702,806 | 1.16B |
| 166 | DOCS | Doximity, Inc. | 4.43B | 3.63% | 5,697,708 | 637.78M |
| 167 | LEGN | Legend Biotech Corporation | 4.42B | -0.38% | 1,369,154 | 1.03B |
| 168 | STVN | Stevanato Group S.p.A. | 4.42B | -0.37% | 496,604 | 1.39B |
| 169 | NVST | Envista Holdings Corporation | 4.37B | -0.89% | 3,096,288 | 2.72B |
| 170 | ALHC | Alignment Healthcare, Inc. | 4.32B | 1.44% | 3,719,549 | 3.95B |
| 171 | MMSI | Merit Medical Systems, Inc. | 4.09B | -0.04% | 516,401 | 1.52B |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.01B | -0.47% | 1,053,280 | 7.70M |
| 173 | AMRX | Amneal Pharmaceuticals, Inc. | 3.99B | -1.03% | 1,833,878 | 3.02B |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.99B | 0.73% | 165,853 | 747.14M |
| 175 | BLLN | BillionToOne, Inc. | 3.90B | 0.97% | 234,695 | 305.11M |
| 176 | TMDX | TransMedics Group, Inc. | 3.83B | -2.01% | 808,385 | 605.49M |
| 177 | VKTX | Viking Therapeutics, Inc. | 3.80B | -0.15% | 2,037,455 | - |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 3.74B | -0.68% | 868,122 | 1.07B |
| 179 | TVTX | Travere Therapeutics, Inc. | 3.74B | -0.78% | 1,363,138 | 490.73M |
| 180 | TWST | Twist Bioscience Corporation | 3.74B | 3.55% | 945,301 | 391.56M |
| 181 | TNGX | Tango Therapeutics, Inc. | 3.72B | -0.39% | 5,157,794 | 62.38M |
| 182 | MMED | MiniMed Group, Inc. | 3.71B | -3.15% | 670,212 | 2.99B |
| 183 | TLX | Telix Pharmaceuticals Limited | 3.61B | 3.63% | 177,593 | 803.79M |
| 184 | LIVN | LivaNova PLC | 3.51B | -1.46% | 394,016 | 1.39B |
| 185 | ORKA | Oruka Therapeutics, Inc. | 3.47B | 1.90% | 1,091,939 | - |
| 186 | HNGE | Hinge Health, Inc. | 3.43B | 2.43% | 430,962 | 587.86M |
| 187 | NAMS | NewAmsterdam Pharma Company N.V. | 3.42B | -5.53% | 1,003,004 | 22.50M |
| 188 | EWTX | Edgewise Therapeutics, Inc. | 3.39B | 1.12% | 1,033,864 | - |
| 189 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.34B | -1.12% | 1,970,156 | 588.99M |
| 190 | BKD | Brookdale Senior Living Inc. | 3.30B | 1.76% | 2,138,812 | 3.05B |
| 191 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.29B | -0.60% | 645,696 | 677.56M |
| 192 | LQDA | Liquidia Corporation | 3.29B | -0.40% | 710,949 | 158.32M |
| 193 | GPCR | Structure Therapeutics Inc. | 3.22B | -3.25% | 835,418 | - |
| 194 | RCUS | Arcus Biosciences, Inc. | 3.20B | 1.47% | 731,360 | 247.00M |
| 195 | ALMS | Alumis Inc. | 3.17B | -4.08% | 1,248,339 | 24.05M |
| 196 | DNLI | Denali Therapeutics Inc. | 3.15B | 2.16% | 1,174,210 | - |
| 197 | ICUI | ICU Medical, Inc. | 3.12B | 0.22% | 222,752 | 2.23B |
| 198 | NKTR | Nektar Therapeutics | 3.09B | 0.46% | 922,217 | 55.23M |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.02B | -3.39% | 1,234,923 | - |
| 200 | PRVA | Privia Health Group, Inc. | 2.99B | 1.45% | 641,223 | 2.12B |
| 201 | OGN | Organon & Co. | 2.96B | 30.93% | 31,875,916 | 6.22B |
| 202 | CON | Concentra Group Holdings Parent, Inc. | 2.93B | -0.78% | 694,556 | 2.16B |
| 203 | ITGR | Integer Holdings Corporation | 2.93B | 1.37% | 556,236 | 1.85B |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 2.89B | 1.75% | 1,090,581 | 376.07M |
| 205 | SUPN | Supernus Pharmaceuticals, Inc. | 2.87B | -1.25% | 482,160 | 718.95M |
| 206 | RLAY | Relay Therapeutics, Inc. | 2.86B | 0.27% | 1,968,383 | 15.36M |
| 207 | TXG | 10x Genomics, Inc. | 2.82B | 3.08% | 1,576,658 | 642.82M |
| 208 | WRBY | Warby Parker Inc. | 2.79B | 1.56% | 1,732,210 | 871.91M |
| 209 | PBH | Prestige Consumer Healthcare Inc. | 2.79B | 2.03% | 362,401 | 1.10B |
| 210 | HAE | Haemonetics Corporation | 2.79B | 0.52% | 489,319 | 1.32B |
| 211 | KLRA | Kailera Therapeutics, Inc. | 2.78B | -10.41% | 1,209,729 | - |
| 212 | KOD | Kodiak Sciences Inc. | 2.77B | -0.82% | 433,995 | - |
| 213 | LFST | LifeStance Health Group, Inc. | 2.75B | 0.86% | 2,693,248 | 1.42B |
| 214 | VCYT | Veracyte, Inc. | 2.73B | 3.56% | 635,399 | 517.15M |
| 215 | SLNO | Soleno Therapeutics, Inc. | 2.73B | -0.21% | 3,281,966 | 190.41M |
| 216 | BEAM | Beam Therapeutics Inc. | 2.72B | -10.11% | 4,713,753 | 139.74M |
| 217 | VERA | Vera Therapeutics, Inc. | 2.70B | -1.82% | 1,721,950 | - |
| 218 | IDYA | IDEAYA Biosciences, Inc. | 2.70B | 0.10% | 648,984 | 218.71M |
| 219 | NHC | National HealthCare Corporation | 2.70B | 1.34% | 109,231 | 1.52B |
| 220 | IMNM | Immunome, Inc. | 2.67B | 2.48% | 590,168 | 6.94M |
| 221 | ELVN | Enliven Therapeutics, Inc. | 2.65B | 0.82% | 667,164 | - |
| 222 | IRON | Disc Medicine, Inc. | 2.63B | 0.78% | 317,359 | - |
| 223 | ADMA | ADMA Biologics, Inc. | 2.62B | 1.62% | 4,221,148 | 510.17M |
| 224 | TARS | Tarsus Pharmaceuticals, Inc. | 2.62B | 0.79% | 723,237 | 451.36M |
| 225 | CLDX | Celldex Therapeutics, Inc. | 2.61B | -0.77% | 597,018 | 1.55M |
| 226 | HTFL | HeartFlow, Inc. | 2.61B | -2.56% | 699,450 | 176.03M |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.59B | 0.49% | 85,081 | 249.60M |
| 228 | ZLAB | Zai Lab Limited | 2.56B | 4.07% | 497,977 | 460.16M |
| 229 | MANE | Veradermics, Incorporated | 2.53B | -2.04% | 345,126 | - |
| 230 | ACHC | Acadia Healthcare Company, Inc. | 2.52B | 0.15% | 2,961,628 | 3.31B |
| 231 | GRDN | Guardian Pharmacy Services, Inc. | 2.38B | 1.62% | 561,891 | 1.45B |
| 232 | XRAY | DENTSPLY SIRONA Inc. | 2.38B | 0.08% | 2,748,849 | 3.68B |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | 2.36B | -0.74% | 1,538,142 | 673.00M |
| 234 | HCM | HUTCHMED (China) Limited | 2.33B | 0.36% | 14,576 | 548.51M |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -3.44% | 603,753 | - |
| 236 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.24B | 2.05% | 2,623,776 | 874.84M |
| 237 | DFTX | Definium Therapeutics, Inc. | 2.24B | -3.35% | 2,621,508 | - |
| 238 | TYRA | Tyra Biosciences, Inc. | 2.24B | 2.45% | 1,051,320 | - |
| 239 | PAHC | Phibro Animal Health Corporation | 2.24B | 0.86% | 208,295 | 1.46B |
| 240 | GRAL | GRAIL, Inc. | 2.23B | 7.44% | 590,611 | 147.17M |
| 241 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | - | 158.18M |
| 242 | AAPG | Ascentage Pharma Group International | 2.20B | 7.21% | 7,239 | 82.08M |
| 243 | ADPT | Adaptive Biotechnologies Corporation | 2.18B | 2.32% | 876,072 | 276.98M |
| 244 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | -0.59% | 2,076,721 | 2.20B |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | -0.99% | 1,275,171 | 283.06M |
| 246 | BHC | Bausch Health Companies Inc. | 2.10B | 1.62% | 1,335,657 | 10.27B |
| 247 | NEOG | Neogen Corporation | 2.08B | 2.03% | 1,997,606 | 870.56M |
| 248 | ZYME | Zymeworks Inc. | 2.07B | 2.44% | 570,590 | 105.97M |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.07B | -1.04% | 2,643,200 | 51.95M |
| 250 | SEM | Select Medical Holdings Corporation | 2.04B | 0.12% | 1,376,820 | 5.45B |
| 251 | CAPR | Capricor Therapeutics, Inc. | 2.04B | 4.16% | 964,532 | 11.13M |
| 252 | AXGN | Axogen, Inc. | 2.04B | 4.92% | 1,509,433 | 225.21M |
| 253 | MESO | Mesoblast Limited | 2.03B | 0.13% | 87,771 | 65.38M |
| 254 | TRVI | Trevi Therapeutics, Inc. | 2.02B | 1.55% | 970,254 | - |
| 255 | STOK | Stoke Therapeutics, Inc. | 2.01B | -2.58% | 398,234 | 184.42M |
| 256 | WGS | GeneDx Holdings Corp. | 2.01B | 3.46% | 457,132 | 427.54M |
| 257 | ESTA | Establishment Labs Holdings Inc. | 1.95B | 1.78% | 301,319 | 211.08M |
| 258 | SNDX | Syndax Pharmaceuticals, Inc. | 1.89B | 1.86% | 1,694,107 | 172.35M |
| 259 | INBX | Inhibrx Biosciences, Inc. | 1.89B | 7.61% | 617,153 | 1.30M |
| 260 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.88B | -1.62% | 686,609 | -665.00K |
| 261 | GLPG | Galapagos NV | 1.88B | -0.14% | 102,891 | 1.31B |
| 262 | MD | Pediatrix Medical Group, Inc. | 1.87B | 1.23% | 470,872 | 1.91B |
| 263 | PHVS | Pharvaris N.V. | 1.87B | 4.73% | 156,026 | - |
| 264 | RXRX | Recursion Pharmaceuticals, Inc. | 1.85B | 0.29% | 9,350,983 | 74.68M |
| 265 | SGRY | Surgery Partners, Inc. | 1.84B | -1.98% | 1,273,800 | 3.31B |
| 266 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | - | 1,928,014 | 9.77M |
| 267 | AORT | Artivion, Inc. | 1.83B | 1.61% | 155,632 | 441.33M |
| 268 | VCEL | Vericel Corporation | 1.82B | 3.60% | 565,694 | 276.26M |
| 269 | ANIP | ANI Pharmaceuticals, Inc. | 1.79B | 0.74% | 204,206 | 883.37M |
| 270 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | -3.99% | 933,298 | 868.45M |
| 271 | PVLA | Palvella Therapeutics, Inc. | 1.77B | -2.72% | 115,645 | - |
| 272 | RAPP | Rapport Therapeutics, Inc. | 1.75B | 0.55% | 230,307 | - |
| 273 | INVA | Innoviva, Inc. | 1.75B | 0.38% | 456,589 | 411.33M |
| 274 | AHG | Akso Health Group | 1.74B | -4.01% | 176,832 | 14.84M |
| 275 | AHCO | AdaptHealth Corp. | 1.74B | 0.55% | 1,280,094 | 3.24B |
| 276 | ADUS | Addus HomeCare Corporation | 1.74B | 1.32% | 203,831 | 1.42B |
| 277 | NRIX | Nurix Therapeutics, Inc. | 1.72B | 0.66% | 575,695 | 71.78M |
| 278 | SION | Sionna Therapeutics, Inc. | 1.71B | -0.63% | 518,006 | - |
| 279 | NUVB | Nuvation Bio Inc. | 1.70B | -2.98% | 4,236,081 | 62.90M |
| 280 | OMCL | Omnicell, Inc. | 1.70B | 2.75% | 460,833 | 1.18B |
| 281 | ALMR | Alamar Biosciences, Inc. | 1.69B | 2.35% | 707,380 | 74.21M |
| 282 | ANAB | AnaptysBio, Inc. | 1.69B | 14.84% | 1,335,620 | 234.60M |
| 283 | ATAI | AtaiBeckley Inc. | 1.69B | -2.94% | 5,977,325 | 4.09M |
| 284 | SNDA | Sonida Senior Living, Inc. | 1.68B | 2.50% | 419,806 | 336.39M |
| 285 | VIR | Vir Biotechnology, Inc. | 1.67B | 0.19% | 1,262,537 | 68.56M |
| 286 | ASTH | Astrana Health, Inc. | 1.67B | 2.40% | 444,709 | 3.18B |
| 287 | ATEC | Alphatec Holdings, Inc. | 1.65B | 6.76% | 4,389,433 | 764.16M |
| 288 | GENB | Generate Biomedicines, Inc. | 1.63B | -0.47% | 279,524 | 31.89M |
| 289 | PRGO | Perrigo Company plc | 1.63B | 1.11% | 2,060,893 | 4.25B |
| 290 | INSP | Inspire Medical Systems, Inc. | 1.62B | -0.07% | 679,227 | 911.98M |
| 291 | NTLA | Intellia Therapeutics, Inc. | 1.61B | -14.11% | 9,028,287 | 67.67M |
| 292 | NBTX | Nanobiotix S.A. | 1.60B | -0.39% | 58,340 | 38.27M |
| 293 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | -1.88% | 575,186 | 123.67M |
| 294 | PLSE | Pulse Biosciences, Inc. | 1.57B | -5.07% | 225,265 | 350.00K |
| 295 | OCS | Oculis Holding AG | 1.56B | -1.23% | 310,591 | 1.51M |
| 296 | HCSG | Healthcare Services Group, Inc. | 1.55B | 3.99% | 993,706 | 1.85B |
| 297 | UFPT | UFP Technologies, Inc. | 1.54B | 0.99% | 243,042 | 602.80M |
| 298 | IMTX | Immatics N.V. | 1.52B | 1.79% | 246,696 | 56.67M |
| 299 | MBX | MBX Biosciences, Inc. | 1.52B | -4.28% | 448,128 | - |
| 300 | DMRA | Damora Therapeutics, Inc. | 1.49B | -2.64% | 166,705 | - |
| 301 | IMCR | Immunocore Holdings plc | 1.49B | 0.24% | 229,591 | 400.02M |
| 302 | BHVN | Biohaven Ltd. | 1.49B | -6.08% | 1,694,545 | - |
| 303 | AGIO | Agios Pharmaceuticals, Inc. | 1.48B | -1.63% | 972,390 | 54.03M |
| 304 | BCAX | Bicara Therapeutics Inc. | 1.48B | -0.83% | 359,366 | - |
| 305 | ATRC | AtriCure, Inc. | 1.48B | 3.79% | 660,409 | 534.53M |
| 306 | HROW | Harrow, Inc. | 1.48B | 2.45% | 500,043 | 272.30M |
| 307 | PGEN | Precigen, Inc. | 1.46B | 4.29% | 3,459,179 | 9.68M |
| 308 | ARDX | Ardelyx, Inc. | 1.46B | -0.17% | 2,254,429 | 407.32M |
| 309 | NVCR | NovoCure Limited | 1.44B | -0.95% | 781,837 | 655.35M |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.43B | -0.77% | 503,984 | 2.50M |
| 311 | AVAH | Aveanna Healthcare Holdings Inc. | 1.42B | 0.61% | 822,381 | 2.43B |
| 312 | PGNY | Progyny, Inc. | 1.42B | 2.83% | 1,439,909 | 1.29B |
| 313 | IOVA | Iovance Biotherapeutics, Inc. | 1.42B | -1.15% | 11,715,211 | 263.50M |
| 314 | VRDN | Viridian Therapeutics, Inc. | 1.42B | -3.51% | 1,052,646 | 70.85M |
| 315 | TNDM | Tandem Diabetes Care, Inc. | 1.39B | -1.55% | 883,179 | 1.01B |
| 316 | ENOV | Enovis Corporation | 1.39B | 5.66% | 835,322 | 2.25B |
| 317 | ARDT | Ardent Health, Inc. | 1.39B | 0.10% | 388,465 | 6.32B |
| 318 | WVE | Wave Life Sciences Ltd. | 1.38B | -1.78% | 2,800,894 | 42.73M |
| 319 | PRCT | PROCEPT BioRobotics Corporation | 1.37B | 0.50% | 1,189,405 | 308.05M |
| 320 | BFLY | Butterfly Network, Inc. | 1.36B | 3.50% | 6,161,002 | 97.61M |
| 321 | OLMA | Olema Pharmaceuticals, Inc. | 1.35B | 1.17% | 661,335 | - |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | 0.37% | 1,269,851 | - |
| 323 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -1.87% | 877,571 | - |
| 324 | NVAX | Novavax, Inc. | 1.34B | 0.86% | 1,788,624 | 1.12B |
| 325 | KMTS | Kestra Medical Technologies, Ltd. | 1.31B | -1.19% | 192,070 | 83.72M |
| 326 | MPLT | MapLight Therapeutics, Inc. | 1.31B | 2.23% | 530,955 | - |
| 327 | SVRA | Savara Inc. | 1.30B | 3.64% | 929,627 | - |
| 328 | CMPS | COMPASS Pathways plc | 1.29B | 4.70% | 10,207,104 | - |
| 329 | CLOV | Clover Health Investments, Corp. | 1.27B | 1.25% | 4,192,948 | 1.92B |
| 330 | STAA | STAAR Surgical Company | 1.27B | 3.34% | 624,096 | 239.44M |
| 331 | ABCL | AbCellera Biologics Inc. | 1.26B | 2.47% | 9,417,136 | 75.13M |
| 332 | GHRS | GH Research PLC | 1.26B | 7.66% | 277,332 | - |
| 333 | MLTX | MoonLake Immunotherapeutics | 1.23B | 1.48% | 672,313 | - |
| 334 | JBIO | Jade Biosciences, Inc. | 1.23B | -0.91% | 766,639 | - |
| 335 | NNNN | Anbio Biotechnology | 1.20B | 0.29% | 15,306 | 8.65M |
| 336 | AZTA | Azenta, Inc. | 1.19B | 3.19% | 825,101 | 595.03M |
| 337 | DBVT | DBV Technologies S.A. | 1.18B | 2.33% | 152,877 | 5.64M |
| 338 | AKTS | Aktis Oncology, Inc. | 1.18B | -3.71% | 267,411 | 6.50M |
| 339 | PHAR | Pharming Group N.V. | 1.17B | 0.24% | 6,311 | 376.13M |
| 340 | URGN | UroGen Pharma Ltd. | 1.17B | -0.82% | 585,357 | 109.79M |
| 341 | CNMD | CONMED Corporation | 1.16B | 2.24% | 312,236 | 1.37B |
| 342 | AVNS | Avanos Medical, Inc. | 1.15B | -0.20% | 1,377,703 | 701.20M |
| 343 | EYPT | EyePoint, Inc. | 1.15B | -0.51% | 625,638 | 31.37M |
| 344 | QURE | uniQure N.V. | 1.14B | 2.79% | 1,005,006 | 16.10M |
| 345 | IRMD | IRADIMED CORPORATION | 1.13B | -0.14% | 63,457 | 83.81M |
| 346 | EVO | Evotec SE | 1.11B | -2.48% | 163,752 | 925.65M |
| 347 | USPH | U.S. Physical Therapy, Inc. | 1.11B | -1.65% | 165,801 | 773.34M |
| 348 | SEPN | Septerna, Inc. | 1.11B | -1.20% | 595,429 | 45.95M |
| 349 | CDNA | CareDx, Inc. | 1.09B | 5.83% | 570,657 | 379.81M |
| 350 | ZBIO | Zenas BioPharma, Inc. | 1.08B | -1.62% | 564,707 | 10.00M |
| 351 | NEO | NeoGenomics, Inc. | 1.08B | 4.80% | 1,253,555 | 727.33M |
| 352 | INNV | InnovAge Holding Corp. | 1.08B | 2.71% | 286,124 | 915.37M |
| 353 | IVA | Inventiva S.A. | 1.06B | -0.81% | 297,650 | 7.94M |
| 354 | ALVO | Alvotech | 1.06B | - | 460,059 | 588.90M |
| 355 | COLL | Collegium Pharmaceutical, Inc. | 1.05B | 0.68% | 373,096 | 780.57M |
| 356 | PNTG | The Pennant Group, Inc. | 1.05B | -0.33% | 213,225 | 947.71M |
| 357 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 1.68% | 1,063,664 | 291.85M |
| 358 | TDOC | Teladoc Health, Inc. | 1.04B | 0.88% | 4,022,658 | 2.53B |
| 359 | BLFS | BioLife Solutions, Inc. | 1.03B | -1.57% | 362,427 | 96.21M |
| 360 | ORIC | ORIC Pharmaceuticals, Inc. | 1.03B | -1.82% | 1,071,913 | - |
| 361 | CRON | Cronos Group Inc. | 1.01B | 3.08% | 1,778,735 | 146.59M |
| 362 | KALV | KalVista Pharmaceuticals, Inc. | 1.01B | 2.88% | 978,676 | 73.62M |
| 363 | PCRX | Pacira BioSciences, Inc. | 992.41M | -3.35% | 525,893 | 726.41M |
| 364 | OMER | Omeros Corporation | 974.11M | 0.07% | 1,523,828 | - |
| 365 | CERT | Certara, Inc. | 969.01M | 5.33% | 3,296,883 | 418.84M |
| 366 | GERN | Geron Corporation | 961.35M | - | 12,919,826 | 183.88M |
| 367 | CTMX | CytomX Therapeutics, Inc. | 957.85M | -1.12% | 2,422,912 | 76.20M |
| 368 | ANNX | Annexon, Inc. | 955.54M | -2.97% | 1,393,813 | - |
| 369 | AMPH | Amphastar Pharmaceuticals, Inc. | 953.49M | 1.90% | 429,698 | 719.89M |
| 370 | XNCR | Xencor, Inc. | 951.94M | 4.26% | 627,218 | 125.58M |
| 371 | OPK | OPKO Health, Inc. | 933.65M | 0.82% | 1,818,343 | 606.88M |
| 372 | PHAT | Phathom Pharmaceuticals, Inc. | 929.33M | -3.78% | 1,485,267 | 175.11M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 922.66M | 2.02% | 419,785 | 1.02B |
| 374 | FTRE | Fortrea Holdings Inc. | 916.30M | 1.77% | 774,119 | 2.72B |
| 375 | EVMN | Evommune, Inc. | 914.15M | -1.78% | 259,584 | 13.00M |
| 376 | JANX | Janux Therapeutics, Inc. | 913.08M | -1.18% | 551,728 | 10.00M |
| 377 | MRVI | Maravai LifeSciences Holdings, Inc. | 912.59M | 2.90% | 1,032,053 | 185.74M |
| 378 | INMD | InMode Ltd. | 912.37M | 0.28% | 404,032 | 370.50M |
| 379 | CMPX | Compass Therapeutics, Inc. | 905.84M | -3.45% | 5,058,845 | 850.00K |
| 380 | SANA | Sana Biotechnology, Inc. | 902.69M | -4.36% | 2,721,944 | - |
| 381 | LBRX | LB Pharmaceuticals Inc | 881.18M | -0.03% | 192,040 | - |
| 382 | DRUG | Bright Minds Biosciences Inc. | 872.11M | 0.54% | 126,170 | - |
| 383 | SSII | SS Innovations International, Inc. | 871.74M | -3.80% | 26,391 | 42.48M |
| 384 | SDGR | Schrödinger, Inc. | 870.40M | 3.33% | 1,153,657 | 255.87M |
| 385 | TALK | Talkspace, Inc. | 865.45M | 0.19% | 1,460,265 | 228.87M |
| 386 | ANRO | Alto Neuroscience, Inc. | 859.49M | -4.63% | 195,017 | - |
| 387 | MGTX | MeiraGTx Holdings plc | 854.30M | -0.97% | 673,398 | 81.39M |
| 388 | TBPH | Theravance Biopharma, Inc. | 847.57M | 0.92% | 277,354 | 107.46M |
| 389 | OMDA | Omada Health, Inc. | 844.40M | 0.77% | 481,905 | 260.21M |
| 390 | BVS | Bioventus Inc. | 839.03M | 3.91% | 384,176 | 568.09M |
| 391 | MNKD | MannKind Corporation | 833.75M | -0.37% | 2,776,174 | 348.97M |
| 392 | ABUS | Arbutus Biopharma Corporation | 827.15M | -1.18% | 8,003,994 | 14.08M |
| 393 | IART | Integra LifeSciences Holdings Corporation | 823.80M | 2.42% | 616,258 | 1.64B |
| 394 | CBIO | Crescent Biopharma, Inc. | 823.70M | -3.42% | 258,528 | 10.84M |
| 395 | SPRY | ARS Pharmaceuticals, Inc. | 823.17M | -0.12% | 2,059,051 | 84.28M |
| 396 | KURA | Kura Oncology, Inc. | 821.94M | -0.11% | 852,928 | 67.48M |
| 397 | CBLL | CeriBell, Inc. | 802.14M | 0.57% | 168,369 | 89.06M |
| 398 | SLS | SELLAS Life Sciences Group, Inc. | 800.94M | -3.88% | 7,225,725 | - |
| 399 | CGEM | Cullinan Therapeutics, Inc. | 800.16M | 2.08% | 638,806 | - |
| 400 | ALLO | Allogene Therapeutics, Inc. | 794.59M | -1.70% | 5,527,351 | 22.00K |
| 401 | GDRX | GoodRx Holdings, Inc. | 791.35M | 0.43% | 846,876 | 796.85M |
| 402 | QDEL | QuidelOrtho Corporation | 789.07M | 3.11% | 1,743,256 | 2.73B |
| 403 | AMN | AMN Healthcare Services, Inc. | 786.65M | 0.30% | 566,273 | 2.73B |
| 404 | SGP | SpyGlass Pharma, Inc. | 786.19M | -0.47% | 91,539 | - |
| 405 | TLRY | Tilray Brands, Inc. | 784.53M | -2.74% | 8,566,929 | 858.28M |
| 406 | EFOR | Everforth, Inc. | 783.46M | -2.87% | 2,569,039 | 3.98B |
| 407 | SLDB | Solid Biosciences Inc. | 779.29M | -3.65% | 736,981 | - |
| 408 | DSGN | Design Therapeutics, Inc. | 772.75M | -1.96% | 413,178 | - |
| 409 | BIOA | BioAge Labs, Inc. | 756.67M | -1.10% | 384,412 | 9.00M |
| 410 | RLMD | Relmada Therapeutics, Inc. | 756.24M | -0.55% | 681,137 | - |
| 411 | NUTX | Nutex Health Inc. | 754.25M | -0.97% | 123,646 | 875.26M |
| 412 | VOR | Vor Biopharma Inc. | 748.30M | -5.54% | 1,075,416 | - |
| 413 | CSTL | Castle Biosciences, Inc. | 741.04M | 3.25% | 341,347 | 344.23M |
| 414 | TENX | Tenax Therapeutics, Inc. | 719.30M | 2.36% | 366,217 | - |
| 415 | DRTS | Alpha Tau Medical Ltd. | 712.00M | 1.38% | 285,491 | - |
| 416 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | - | 1,931,965 | 49.80M |
| 417 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 702.69M | -2.12% | 385,146 | - |
| 418 | EHAB | Enhabit, Inc. | 696.94M | - | 1,124,346 | 1.06B |
| 419 | GYRE | Gyre Therapeutics, Inc. | 679.38M | - | 32,192 | 116.59M |
| 420 | FBRX | Forte Biosciences, Inc. | 671.93M | -4.89% | 189,000 | - |
| 421 | ARVN | Arvinas, Inc. | 667.75M | 0.19% | 635,130 | 262.60M |
| 422 | BWAY | BrainsWay Ltd. | 665.25M | 3.94% | 82,914 | 52.23M |
| 423 | PRME | Prime Medicine, Inc. | 655.19M | -3.65% | 1,593,855 | 4.63M |
| 424 | IRWD | Ironwood Pharmaceuticals, Inc. | 640.82M | 3.69% | 1,323,753 | 296.15M |
| 425 | PSNL | Personalis, Inc. | 638.54M | 3.39% | 2,443,519 | 69.65M |
| 426 | TRAX | First Tracks Biotherapeutics, Inc. | 631.04M | -4.42% | 762,697 | - |
| 427 | ETON | Eton Pharmaceuticals, Inc. | 628.09M | 0.22% | 237,837 | 79.95M |
| 428 | HSTM | HealthStream, Inc. | 624.50M | 1.96% | 199,257 | 304.06M |
| 429 | ABSI | Absci Corporation | 602.90M | -0.76% | 4,391,472 | 2.80M |
| 430 | ACRS | Aclaris Therapeutics, Inc. | 597.68M | -5.49% | 1,508,191 | 7.83M |
| 431 | SIBN | SI-BONE, Inc. | 597.11M | 0.90% | 375,777 | 200.93M |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 595.88M | -0.30% | 708,308 | 106.47M |
| 433 | ANL | Adlai Nortye Ltd. | 592.00M | -0.74% | 322,214 | 5.00M |
| 434 | PROK | ProKidney Corp. | 585.80M | -3.00% | 703,136 | 893.00K |
| 435 | STTK | Shattuck Labs, Inc. | 585.00M | 1.18% | 231,921 | 1.00M |
| 436 | CRMD | CorMedix Inc. | 581.94M | 1.23% | 656,966 | 311.71M |
| 437 | PHR | Phreesia, Inc. | 579.68M | 7.80% | 1,462,476 | 480.59M |
| 438 | PRTA | Prothena Corporation plc | 578.70M | 0.19% | 287,824 | 9.68M |
| 439 | TCMD | Tactile Systems Technology, Inc. | 570.35M | 2.54% | 346,068 | 329.52M |
| 440 | CTKB | Cytek Biosciences, Inc. | 565.62M | 3.29% | 577,636 | 201.49M |
| 441 | NPCE | NeuroPace, Inc. | 565.60M | -0.41% | 109,167 | 99.99M |
| 442 | OCGN | Ocugen, Inc. | 561.94M | -0.60% | 6,141,384 | 4.41M |
| 443 | RIGL | Rigel Pharmaceuticals, Inc. | 559.76M | -1.40% | 306,286 | 294.28M |
| 444 | STRO | Sutro Biopharma, Inc. | 552.19M | -4.31% | 344,351 | 102.48M |
| 445 | KYTX | Kyverna Therapeutics, Inc. | 548.40M | 1.23% | 1,489,115 | - |
| 446 | EMBC | Embecta Corp. | 546.01M | 0.77% | 529,350 | 1.08B |
| 447 | AGMB | AgomAb Therapeutics NV | 538.54M | 3.27% | 59,615 | - |
| 448 | TECX | Tectonic Therapeutic, Inc. | 535.88M | 0.35% | 255,779 | - |
| 449 | ENGN | enGene Therapeutics Inc. | 535.25M | -1.84% | 222,225 | - |
| 450 | AVR | Anteris Technologies Global Corp. | 527.86M | 0.90% | 663,452 | 1.91M |
| 451 | VREX | Varex Imaging Corporation | 525.25M | 2.20% | 363,132 | 854.40M |
| 452 | LYEL | Lyell Immunopharma, Inc. | 522.79M | -5.04% | 53,469 | 36.00K |
| 453 | EIKN | Eikon Therapeutics, Inc. | 522.71M | -9.77% | 176,849 | - |
| 454 | IMMX | Immix Biopharma, Inc. | 522.17M | -3.15% | 385,231 | - |
| 455 | FULC | Fulcrum Therapeutics, Inc. | 522.15M | -2.97% | 839,113 | 80.00M |
| 456 | VSTM | Verastem, Inc. | 519.15M | -5.14% | 1,692,805 | 30.91M |
| 457 | CATX | Perspective Therapeutics, Inc. | 514.22M | - | 1,433,505 | 884.00K |
| 458 | ZURA | Zura Bio Limited | 510.46M | -2.54% | 642,677 | - |
| 459 | MDXG | MiMedx Group, Inc. | 509.58M | 2.39% | 1,691,922 | 418.63M |
| 460 | UPB | Upstream Bio, Inc. | 506.11M | -3.02% | 558,812 | 2.85M |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 462 | ADCT | ADC Therapeutics SA | 501.13M | -0.51% | 933,906 | 81.36M |
| 463 | AQST | Aquestive Therapeutics, Inc. | 497.94M | 0.25% | 1,090,974 | 44.55M |
| 464 | BBNX | Beta Bionics, Inc. | 497.75M | -2.27% | 799,853 | 110.24M |
| 465 | OFIX | Orthofix Medical Inc. | 495.78M | 1.65% | 154,598 | 822.31M |
| 466 | ESPR | Esperion Therapeutics, Inc. | 491.64M | - | 7,049,747 | 403.14M |
| 467 | FDMT | 4D Molecular Therapeutics, Inc. | 479.88M | -2.19% | 514,601 | 85.21M |
| 468 | CADL | Candel Therapeutics, Inc. | 476.11M | -7.67% | 1,691,672 | - |
| 469 | ARMP | Armata Pharmaceuticals, Inc. | 473.30M | -4.51% | 53,365 | 4.90M |
| 470 | PRLD | Prelude Therapeutics Incorporated | 472.60M | 6.82% | 865,216 | 12.14M |
| 471 | KMDA | Kamada Ltd. | 471.87M | 0.24% | 21,634 | 180.46M |
| 472 | LRMR | Larimar Therapeutics, Inc. | 471.63M | 0.89% | 1,107,232 | - |
| 473 | PACB | Pacific Biosciences of California, Inc. | 471.12M | -0.64% | 11,370,526 | 160.01M |
| 474 | VALN | Valneva SE | 470.89M | 3.19% | 148,804 | 205.07M |
| 475 | FLGT | Fulgent Genetics, Inc. | 470.46M | 1.75% | 277,490 | 322.67M |
| 476 | AURA | Aura Biosciences, Inc. | 466.73M | 0.14% | 299,510 | - |
| 477 | CTNM | Contineum Therapeutics, Inc. | 463.34M | -0.08% | 138,397 | - |
| 478 | ANGO | AngioDynamics, Inc. | 462.67M | -0.89% | 237,652 | 313.73M |
| 479 | DNA | Ginkgo Bioworks Holdings, Inc. | 458.09M | 2.21% | 517,461 | 170.16M |
| 480 | TRDA | Entrada Therapeutics, Inc. | 454.68M | -1.41% | 161,013 | 25.42M |
| 481 | RGNX | REGENXBIO Inc. | 452.17M | -2.56% | 756,829 | 170.44M |
| 482 | XOMA | XOMA Royalty Corporation | 451.61M | -0.08% | 89,647 | 52.15M |
| 483 | MYGN | Myriad Genetics, Inc. | 451.44M | -0.21% | 735,772 | 824.50M |
| 484 | CGC | Canopy Growth Corporation | 448.11M | -2.87% | 18,662,097 | 203.04M |
| 485 | EPRX | Eupraxia Pharmaceuticals Inc. | 444.11M | -1.24% | 167,710 | - |
| 486 | ASMB | Assembly Biosciences, Inc. | 442.09M | -1.62% | 56,974 | 72.30M |
| 487 | CLYM | Climb Bio, Inc. | 436.60M | 1.33% | 260,932 | - |
| 488 | AVIR | Atea Pharmaceuticals, Inc. | 435.81M | -0.91% | 209,912 | - |
| 489 | AGL | agilon health, inc. | 434.95M | -0.42% | 281,948 | 5.93B |
| 490 | LXEO | Lexeo Therapeutics, Inc. | 433.41M | -2.66% | 940,450 | - |
| 491 | SRTA | Strata Critical Medical, Inc. | 425.32M | 3.36% | 802,107 | 197.14M |
| 492 | BNTC | Benitec Biopharma Inc. | 423.73M | -2.60% | 140,920 | - |
| 493 | NGNE | Neurogene Inc. | 422.09M | 0.30% | 273,080 | 925.00K |
| 494 | KIDS | OrthoPediatrics Corp. | 415.86M | -0.12% | 242,050 | 236.35M |
| 495 | EBS | Emergent BioSolutions Inc. | 414.71M | -0.74% | 398,647 | 742.90M |
| 496 | IVVD | Invivyd, Inc. | 412.89M | -3.31% | 1,412,141 | 53.43M |
| 497 | NMRA | Neumora Therapeutics, Inc. | 411.05M | 0.90% | 854,707 | - |
| 498 | VNDA | Vanda Pharmaceuticals Inc. | 407.25M | 2.99% | 1,037,092 | 216.11M |
| 499 | VTVT | vTv Therapeutics Inc. | 406.54M | -6.00% | 129,104 | 17.00K |
| 500 | PRTC | PureTech Health plc | 402.93M | -4.56% | 7,046 | 6.39M |